GE9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genmab A/S

Watchlist Manager

Watchlist

Price: 252.3 EUR 0.88%

Market Cap: €16.5B

G	Genmab A/S DUS:GE9	DK
A	Avis Budget Group Inc F:CUCA	US
	Futu Holdings Ltd NASDAQ:FUTU	HK
T	Teleperformance SE XBER:RCF	FR
G	Golden Ocean Group Ltd F:KT31	BM
T	Tyler Technologies Inc SWB:TYP	US
	ONEOK Inc NYSE:OKE	US
	Freshworks Inc F:7DF	US
	Vision Marine Technologies Inc XTSX:VMAR	CA
	Amcor PLC F:4850	CH
	Denka Co Ltd F:DIK	JP
C	Carter's Inc F:HCH	US
P	PetroChina Co Ltd DUS:PC6	CN
D	Doxa AB XBER:1DO	SE

Profitability Summary

Genmab A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

93%

Gross Margin is Increasing

45% > 93%

Exceptional Operating Margin

33%

Strong 3Y Average Operating Margin

33%

Declining Operating Margin

39% > 33%

Healthy Net Margin

21%

Strong 3Y Average Net Margin

30%

Declining Net Margin

28% > 21%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

33%

Declining Free Cash Flow Margin

35% > 22%

Positive ROE

15%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

39%

Declining ROIC

76% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.